Document |
Document Title |
JP2004509967A |
The first aspect of the present invention relates to transition metal complexes having the formula:wherein M is a radioactive metal having a valence of +2, +3, +4, or +5; m<+> designates the charge of the metal complex, each R is indepen...
|
JP2004099548A |
To provide a method for efficiently producing a rhenium complex having various heterocyclic ligands and useful as various functional materials in a short time.The method for producing the rhenium complex having a plurality of nitrogen-co...
|
JP3502099B2 |
The invention provides antioxidant salen-metal complexes in a form suitable for pharmaceutical administration to treat or prevent a disease associated with cell or tissue damage produced by free radicals such as superoxide.
|
JP3497165B2 |
Chiral catalysts for enantioselectively epoxidizing a prochiral olefin and for enantioselectively oxidizing a prochiral sulfide are disclosed, together with methods of using such catalysts. In accordance with one aspect of the invention,...
|
JP2004026828A |
To provide a compound which can be used to enhance MR imaging and as a photosensitizing compound used in photosensitizing therapy for tumors and other hyperproliferative tissues.The compound which is a chemically bonded material of a pho...
|
JP2004502695A |
A process for the preparation of manganese complexes of salen compounds which comprises carrying out the reaction of a salen compound with a manganese compound in DMF is described. In a preferred embodiment, the salen compound itself is ...
|
JP2004501893A |
Pamoic acid or its derivatives of formula (I) are used to treat diseases characterized by deposits of amyloid aggregates.
|
JP3487847B2 |
Chiral catalysts for enantioselectively epoxidizing a prochiral olefin are disclosed, together with methods of using such catalysts. In accordance with one aspect of the invention, the catalyst is a salen derivative which has general str...
|
JP2004002305A |
To provide a method for producing a new complex for catalyst suitable for polymerizing an olefin, and to provide a method of (co)polymerizing the olefin using the complex.The complex for use in the (co)polymerizing the olefin( e.g. suspe...
|
JP2004002438A |
To provide a compound forming a long life triplet state in high yield, having properties to act as an efficient photosensitizer in forming a singlet oxygen and enhanced in usefulness with its high chemical stability together with suitabl...
|
JP2003340287A |
To obtain a catalyst for enanthio selective epoxidation of a polychiralolefin and enanthio selective oxidation of a polychiralsulfide, and to provide a method using this catalyst. A catalyst consisting of a salene derivative having a gen...
|
JP2003335809A |
To provide an olefin polymerization catalyst.The olefin polymerization catalyst component is obtained by reacting a tripyridylamine compound to be represented by formula (1) (wherein R1, R5, and R9 are each independently a nitro group, a...
|
JP2003535005A |
The invention relates to novel aminocarboxylate ligands that are suitable for complexing with a radionuclide, and are useful as therapeutic agents and as imaging agents for diagnostic purposes. In accordance with the present invention, a...
|
JP2003534348A |
The invention concerns radiopharmaceutical products suitable for the selective labeling of lymphomas containing a metal complex with the formula:in which M is chosen from among 99mTc, 186Re and 188Re, and R1 represents an alkyl, cycloalk...
|
JP2003527403A |
Olefins, such as ethylene, are polymerized using as a polymerization catalyst a complex of a selected transition metal with an anionic ligand that has at least three atoms that may coordinate to the transition metal. Also disclosed are t...
|
JP2003525282A |
The present invention relates to novel ligands for forming metal complexes that absorb or fluoresce in the visible or near-infrared (NIR) region of the electromagnetic spectrum, new complexes incorporating such ligands, process for prepa...
|
JP2003231678A |
To obtain a cyclic amide transition metal complex having a bleaching activation ability, a bleaching catalyst composed of the complex and a bleaching agent composition having sufficient bleaching effects even at low temperatures, slight ...
|
JP3429456B2 |
To provide a method for reducing a porphyrin complex having a higher valence transition metal as the central metal atom to the corresponding lower valence metal complex to intend, for example, to easily prepare, for example, a lower vale...
|
JP2003517457A |
Radioimaging agents, which exhibit high uptake and retention in the myocardium are disclosed.
|
JP2003517490A |
A family of organometallic liquid absorbents that can have their thermophysical properties tailored for specific applications. Processes to manufacture these liquid absorbents and methods to optimize their thermodynamic properties are in...
|
JP2003517490A5 |
|
JP2003515541A |
Transition metal-cyclopentadienyl-tropane conjugate compounds are described. Methods for preparing transition metal-cyclopentadienyl-tropane conjugate compounds are also described. Transition metal-cyclopentadienyl-tropane conjugate comp...
|
JP3400988B2 |
Catalyst systems useful for the polymerisation of 1-olefins are disclosed, which contain nitrogen-containing transition metal compounds comprising the skeletal unit depicted in Formula (B), wherein M is Fe[II], Fe[III], Ru[II], Ru[III] o...
|
JP2003509423A |
The present invention relates to compounds which are effective as catalysts for dismutating superoxide and, more particularly, the manganese or iron complexes of substituted, unsaturated heterocyclic pentaazacyclopentadecane ligands whic...
|
JP2003509338A |
A process for making a solid composition comprising alkoxide groups, chloride groups, one or more metals, M, in the +2 oxidation state selected from Mg, Ca, Mn, Cu, Co or Zn, and one or more metals, T, in the +3, +4 or +5 oxidation state...
|
JP3385048B2 |
A compound of the formulae where at least one R is -(A)p-R2 where (A)p is a linking group and R2 is a hypoxia localizing noiety; and wherein the other R groups are the same, or different and are independently selected from hydrogen, halo...
|
JP2003503407A |
A compound of formula corresponding to either formula (Ia) or (Ib): wherein: M represents a molecule that can be used for the treatment or diagnosis of pathologies caused by attack on the cartilage, R1, R2 and R3 represent alkyl, or R1, ...
|
JP2003503415A |
The invention relates to novel aminocarboxylate ligands that are suitable for complexing with a radionuclide, and are useful as imaging agents for diagnostic purposes. In accordance with the present invention, a method of preparing a com...
|
JP2003501432A |
This invention provides a novel class of substituted macrocyclic metallic complexes. The complexes are useful as peroxynitrite decomposition catalysts. Pharmaceutical compositions, and methods of making and using the compounds, or a phar...
|
JP2003500174A |
The present invention relates to biomaterials modified with non-proteinaceous catalysts for the dismutation of superoxide, and processes for making such materials. This modification may be by covalent conjugation, copolymerization, or ad...
|
JP2002544288A |
[Task] Provided is a method for producing a metal complex having improved catalytic properties for polymerizing an olefin, particularly propylene, and a polyolefin having improved physical properties (high crystallinity and high strength...
|
JP2002542307A |
Compounds having the formula: are disclosed. M1 and M2 are the same or different and are transition metal atoms or ions; Z2 and Z3, independently, are the atoms necessary to complete a 3-12 membered heterocyclic ring; Z1 is an alkylene o...
|
JP2002338569A |
To provide a material of a dopamine transporter(DAT)-imaging agent radiolabeled by technetium or rhenium, capable of adding blood-brain barrier, and having high compatibility with and selectivity of the DAT.This radio active medicinal co...
|
JP2002539113A |
The present invention relates to novel manganese complexes of salen ligands and the use thereof as catalysts that enhance the action of peroxy compounds in washing, cleaning, and disinfecting processes.
|
JP3341001B2 |
Novel complexes of technetium (<99>Tc or <99m>Tc) which contain the moiety Tc=NR, Tc-N=NY or Tc(-N=NY)2, and a ligand which confers biological target-seeking properties on the complex, wherein R represents an aryl group, a substituted or...
|
JP2002302698A |
To improve the oxidation and a bleaching action of a peroxide, especially an inorganic peroxide at a temperature lower than 80°C, especially withing the temperature range of about 15°C-45°C.As a bleaching catalyst, a compound represen...
|
JP2002280179A |
To provide an organic luminescent element having extremely high efficiency, high luminance, a long-life optical output and extremely high durability, showing various kinds of luminescent hues, easy to manufacture and producible at a rela...
|
JP2002531457A |
(57) [Summary] The present invention is formulated by contacting a diquaternary cistetracycle precursor with hydrogen in the presence of a palladium catalyst in an aqueous solution having a pH of at least about 10 at a temperature of abo...
|
JP2002262781A |
To process a composition comprising a methionine-transition metal complex or (and) a chitosan oligomer-transition metal complex, and amino acid into an effective feed additive in an easy-to-use shape, and finally commercialize the compos...
|
JP3322877B2 |
PCT No. PCT/GB93/01666 Sec. 371 Date Oct. 6, 1993 Sec. 102(e) Date Oct. 6, 1993 PCT Filed Aug. 5, 1993 PCT Pub. No. WO94/03271 PCT Pub. Date Feb. 17, 1994A compound of formula (I): (I) n which M is a transition metal ion; A is a counter-...
|
JP2002527031A |
A 99Mo/99mTc generator system includes a sorbent column loaded with a composition containing 99Mo. The sorbent column has an effluent end in fluid communication with an anion-exchange column for concentrating 99mTc eluted from the sorben...
|
JP3315112B2 |
The present invention involves a novel tripyrrole dimethine-derived "expanded porphyrin" (texaphyrin), the synthesis of such compounds, their analogs or derivatives and their uses. These expanded porphyrin-like macrocycles are efficient ...
|
JP2002523558A |
The present invention relates to the use of certain manganese complexes as catalysts for reactions with peroxy compounds for bleaching colored stains on hard surfaces. The invention also relates to cleaning agents for hard surfaces compr...
|
JP2002522444A |
A process for producing a transition metal complex of formula (B) wherein M is Fe[II], Fe[III], Co[I], Co[II], Co[III], Mn[l], Mn[II], Mn[III], Mn(IV], Ru[II], Ru[III] or Ru[IV]; X represents an atom or group covalently or ionically bond...
|
JP2002522545A |
Compounds and methods of preparing compounds represented by structural formula (I):wherein X represents any suitable counter-anion;R1 and R2 independently represent hydrogen, C1-6 alkoxy or nitro;R3, R4, R5 and R6 each independently repr...
|
JP2002521384A |
The invention relates to paramagnetic 3-,8-substituted deuteroporphyrin derivatives having different substituents in positions 13 and 17 of the porphyrin skeleton, diagnostic substances containing said compounds, their use in magnetic re...
|
JP2002179724A |
To obtain a catalyst component for α-olefin polymerization using a manganese complex, a group VII transition metal complex which has never been known as a catalyst component and/or a catalyst for α-olefin polymerization, to obtain a ca...
|
JP2002513823A |
An activated tridentate-, monoanionic-ligand-based transition metal catalyst in a reduced oxidation state for olefin polymerization is disclosed. Transition metal catalyst precursors for these catalysts have the formulae:in which M is a ...
|
JP3271009B2 |
To provide a single-crystal asymmetric molecular magnet having magnetism, optical activity, colored transparency, a relatively high transition temperature, etc. This asymmetric molecular magnet is composed of a single crystal expressed b...
|
JP3271259B2 |
PURPOSE: To obtain as new compound useful for radiolabelling of macromolecules such as monoclonal antibodies or the like. CONSTITUTION: A complex of 99mTc with a ligand L of formula I (R is H, OH, an alkyl or the like, R and R1 together ...
|